A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines is a research paper published in Neuro-Oncology Advances (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R25NS108937-01
National Institutes of Health
Grant: 2R25NS108937-06
University of MIami Neurosurgery eDucation Strategy UMINDS
NINDS NIH HHS
Grant: R25 NS108937
FWCI
0.39
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals